Difference between revisions of "Combined Nuclear Medicine Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
m |
m (→2016) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | *[[Media:10 23 2015 QIBA Nuclear Medicine Leadership Call Summary-FINAL.pdf|10.23.2015 QIBA Nuclear Medicine Leadership Call Summary]] | + | ==2016== |
+ | |||
+ | *[[Media:03 25 2016 QIBA Nuclear Medicine Leadership Call Summary-FINAL-AMS-esp.pdf|03.25.2016 QIBA Nuclear Medicine Leadership Call Summary]] | ||
+ | *[[Media:02 26 2016 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|02.26.2016 QIBA Nuclear Medicine Leadership Call Summary]] | ||
+ | |||
+ | ==2015== | ||
+ | *[[Media:10 23 2015 QIBA Nuclear Medicine Leadership Call Summary-FINAL-ep.pdf|10.23.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | *[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:06 26 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|06.26.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:06 26 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|06.26.2015 QIBA Nuclear Medicine BCs Call Summary]] | ||
*[[Media:05 15 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|05.15.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:05 15 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|05.15.2015 QIBA Nuclear Medicine BCs Call Summary]] | ||
*[[Media:04 10 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT-h.pdf|04.10.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:04 10 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT-h.pdf|04.10.2015 QIBA Nuclear Medicine BCs Call Summary]] |